DENVER–(BUSINESS WIRE)– #batterystorage–Barrell Lithium Surpasses 62,000 Net Mineral Acres in Smackover Trend; Closes Oversubscribed Series C Funding Round
Month: September 2026
DENVER–(BUSINESS WIRE)– #batterystorage–Barrell Lithium Surpasses 62,000 Net Mineral Acres in Smackover Trend; Closes Oversubscribed Series C Funding Round
BOSTON–(BUSINESS WIRE)–KCC is pleased to announce the release of RiskInsight® 4.16, the latest evolution in open loss modeling software. RiskInsight 4.16 expands workflow automation through enhanced API capabilities, faster analysis performance, and significant reductions in database storage requirements. RiskInsight’s extensive API suite supports integration with modeling, underwriting, and portfolio management systems, enabling (re)insurers to seamlessly integrate the KCC models into existi
BOSTON–(BUSINESS WIRE)–KCC is pleased to announce the release of RiskInsight® 4.16, the latest evolution in open loss modeling software. RiskInsight 4.16 expands workflow automation through enhanced API capabilities, faster analysis performance, and significant reductions in database storage requirements. RiskInsight’s extensive API suite supports integration with modeling, underwriting, and portfolio management systems, enabling (re)insurers to seamlessly integrate the KCC models into existi
PARMA, Italy–(BUSINESS WIRE)–Chiesi Group (Chiesi) today announced the appointment of David Khougazian as Group Chief Executive Officer (CEO), effective 15 October 2026. David joins Chiesi following a distinguished international career spanning more than 25 years across the global healthcare and life sciences sectors. Most recently, he served as Executive Partner, Growth, and Head of Global Engagement at Flagship Pioneering, where he supported the growth and development of science-driven heal
PARMA, Italy–(BUSINESS WIRE)–Chiesi Group (Chiesi) today announced the appointment of David Khougazian as Group Chief Executive Officer (CEO), effective 15 October 2026. David joins Chiesi following a distinguished international career spanning more than 25 years across the global healthcare and life sciences sectors. Most recently, he served as Executive Partner, Growth, and Head of Global Engagement at Flagship Pioneering, where he supported the growth and development of science-driven heal
PARMA, Italy–(BUSINESS WIRE)–Il Gruppo Chiesi (Chiesi) annuncia oggi la nomina di David Khougazian a Chief Executive Officer (CEO) del Gruppo, con effetto dal 15 ottobre 2026. David entra in Chiesi dopo una prestigiosa carriera internazionale di oltre 25 anni nell’healthcare e nelle life sciences. Più recentemente, ha ricoperto il ruolo di Executive Partner, Growth e Head of Global Engagement presso Flagship Pioneering, dove ha supportato la crescita e lo sviluppo di aziende healthcare innova
PARMA, Italy–(BUSINESS WIRE)–Il Gruppo Chiesi (Chiesi) annuncia oggi la nomina di David Khougazian a Chief Executive Officer (CEO) del Gruppo, con effetto dal 15 ottobre 2026. David entra in Chiesi dopo una prestigiosa carriera internazionale di oltre 25 anni nell’healthcare e nelle life sciences. Più recentemente, ha ricoperto il ruolo di Executive Partner, Growth e Head of Global Engagement presso Flagship Pioneering, dove ha supportato la crescita e lo sviluppo di aziende healthcare innova
FORM 8.5 (EPT/RI)
PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY
Rule 8.5 of the Takeover Code (the “Code”)
1. KEY INFORMATION
| (a) Name of exempt principal trader: | Investec Bank Plc |
| (b) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree |
Advanced Medical Solutions Group Plc |
| (c) Name of the party to the offer with which exempt principal trader is connected: | Investec is Advisor & Joint Broker to Advanced Medical Solutions Group plc |
| (d) Date dealing undertaken: | 14th September 2026 |
| (e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer? If it is a cash offer or possible cash offer, state “N/A” |
N/A |
2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER
Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.
The currency of all prices and other monetary amounts should be stated.
(a) Purchases and sales
| Class of relevant security | Purchases/ sales | Total number of securities | Highest price per unit paid/received | Lowest price per unit paid/received |
|
Ordinary shares |
Purchase |
117,999 |
281 | 280.75 |
|
Ordinary shares |
Sales |
250,000 |
280.75 | 280.75 |
(b) Cash-settled derivative transactions
| Class of relevant security | Product description e.g. CFD |
Nature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short position |
Number of reference securities | Price per unit |
| N/A | N/A | N/A | N/A | N/A |
(c) Stock-settled derivative transactions (including options)
(i) Writing, selling, purchasing or varying
| Class of relevant security | Product description e.g. call option | Writing, purchasing, selling, varying etc. | Number of securities to which option relates | Exercise price per unit | Type e.g. American, European etc. |
Expiry date | Option money paid/ received per unit |
| N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
(ii) Exercise
| Class of relevant security | Product description e.g. call option |
Exercising/ exercised against | Number of securities | Exercise price per unit |
| N/A | N/A | N/A | N/A | N/A |
(d) Other dealings (including subscribing for new securities)
| Class of relevant security | Nature of dealing e.g. subscription, conversion |
Details | Price per unit (if applicable) |
| N/A | N/A | N/A | N/A |
3. OTHER INFORMATION
(a) Indemnity and other dealing arrangements
| Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none” |
|
None |
(b) Agreements, arrangements or understandings relating to options or derivatives
| Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state “none” |
| None |
| Date of disclosure: | 15th September 2026 |
| Contact name: | Priyali Bhattacharjee |
| Telephone number: | +91-9923757332 |
Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.
The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s dealing disclosure requirements on +44 (0)20 7638 0129.
The Code can be viewed on the Panel’s website at ssssssswwww.thetakeoverpanel.org.uk.
FORM 8.5 (EPT/RI)
PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY
Rule 8.5 of the Takeover Code (the “Code”)
1. KEY INFORMATION
| (a) Name of exempt principal trader: | Investec Bank Plc |
| (b) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree |
Advanced Medical Solutions Group Plc |
| (c) Name of the party to the offer with which exempt principal trader is connected: | Investec is Advisor & Joint Broker to Advanced Medical Solutions Group plc |
| (d) Date dealing undertaken: | 14th September 2026 |
| (e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer? If it is a cash offer or possible cash offer, state “N/A” |
N/A |
2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER
Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.
The currency of all prices and other monetary amounts should be stated.
(a) Purchases and sales
| Class of relevant security | Purchases/ sales | Total number of securities | Highest price per unit paid/received | Lowest price per unit paid/received |
|
Ordinary shares |
Purchase |
117,999 |
281 | 280.75 |
|
Ordinary shares |
Sales |
250,000 |
280.75 | 280.75 |
(b) Cash-settled derivative transactions
| Class of relevant security | Product description e.g. CFD |
Nature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short position |
Number of reference securities | Price per unit |
| N/A | N/A | N/A | N/A | N/A |
(c) Stock-settled derivative transactions (including options)
(i) Writing, selling, purchasing or varying
| Class of relevant security | Product description e.g. call option | Writing, purchasing, selling, varying etc. | Number of securities to which option relates | Exercise price per unit | Type e.g. American, European etc. |
Expiry date | Option money paid/ received per unit |
| N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
(ii) Exercise
| Class of relevant security | Product description e.g. call option |
Exercising/ exercised against | Number of securities | Exercise price per unit |
| N/A | N/A | N/A | N/A | N/A |
(d) Other dealings (including subscribing for new securities)
| Class of relevant security | Nature of dealing e.g. subscription, conversion |
Details | Price per unit (if applicable) |
| N/A | N/A | N/A | N/A |
3. OTHER INFORMATION
(a) Indemnity and other dealing arrangements
| Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none” |
|
None |
(b) Agreements, arrangements or understandings relating to options or derivatives
| Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state “none” |
| None |
| Date of disclosure: | 15th September 2026 |
| Contact name: | Priyali Bhattacharjee |
| Telephone number: | +91-9923757332 |
Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.
The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s dealing disclosure requirements on +44 (0)20 7638 0129.
The Code can be viewed on the Panel’s website at ssssssswwww.thetakeoverpanel.org.uk.